Vascular dementia
Conditions
Interventions
Sponsors
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) All the inpatients and / or outpatients who used compound Cistanche yizhi capsule at least once, regardless of the duration of medication, were regarded as the monitoring population; (2) Outpatients and inpatients with vascular dementia (may have comorbidities); (3) The patient or his / her legal representative informed the research purpose, method and possible risks in a clear and normal mental state, did not interfere with the decision of the patient or his / her legal agent, agreed to participate in the study, and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Loose stool; (2) Patients with serious diseases such as heart, brain, liver, kidney or hematopoietic system; (3) Abnormal liver and kidney function, abnormal ECG with clinical significance; (4) Known to be allergic to the components of compound Congrong yizhi capsule; (5) Patients are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver function (ALT, AST, GGT);Renal function (CRE, BUN);Mini-mental State Examination, MMSE;routine blood test;routine urine test; | — |
Countries
China
Contacts
Public ContactLu Yan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Outcome results
None listed